BioCentury
ARTICLE | Clinical News

Axanum aspirin/esomeprazole magnesium regulatory update

June 7, 2010 7:00 AM UTC

FDA issued a complete response letter for an NDA for Axanum aspirin/esomeprazole to reduce the risk of low-dose aspirin-associated gastric and/or duodenal ulcers. AstraZeneca did not disclose details ...